<DOC>
	<DOCNO>NCT01701583</DOCNO>
	<brief_summary>This study look change cell proteins people chronic hive treat omalizumab .</brief_summary>
	<brief_title>Effect Omalizumab ( Xolair ) Basophils Patients With Chronic Idiopathic Urticaria</brief_title>
	<detailed_description>The purpose study evaluate change protein produce white blood cell ( basophil ) patient chronic hive treat respond omalizumab .</detailed_description>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>Chronic urticaria ( hive ) 6 week . No improvement standard dose antihistamine ( loratadine 10 mg daily , desloratadine 5 mg daily , fexofenadine 180 mg daily , cetirizine 10 mg daily , levocetirizine 5 mg daily ) Taken oral steroid 1 month prior begin study . Taken immunomodulatory drug ( sulfasalazine , hydroxychloroquine , cyclosporine , methotrexate ) 1 month prior begin study . Physical urticaria primary diagnosis . Known allergic precipitant urticaria food . Urticarial Vasculitis . Anemia . Asthma . Serum Immunoglobulin E ( IgE ) &gt; 700 IU/ml . Women childbearing potential use contraception method ( ) , well woman pregnant and/or breastfeeding . Known sensitivity omalizumab class drug . Use investigational agent last 1 month . Untreated intercurrent illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Chronic Idiopathic Urticaria</keyword>
	<keyword>CIU</keyword>
	<keyword>Urticaria</keyword>
	<keyword>Chronic Hives</keyword>
	<keyword>Xolair</keyword>
</DOC>